| Product Name | Tadocizumab |
|---|---|
| CAS | 339086-80-5 |
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥5200.00 | Visible after login | |
| 5 mg | 3-5days | ¥22100.00 | Visible after login | |
| 10 mg | 3-5days | ¥38000.00 | Visible after login | |
| 50 mg | 3-5days | ¥152000.00 | Visible after login | |
| 100 mg | 3-5days | ¥275000.00 | Visible after login |
| Product Name | Tadocizumab |
|---|---|
| CAS | 339086-80-5 |
| Storage condition | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.